DAWN Day One Biopharmaceuticals Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
15:11
Mar 06
Mar 06
The author is reaffirming a previous long call ("The stock $DAWN is a good long idea. Probably doubles."), indicating the thesis is still active but requires patience to play out.
HIGH
About DAWN Analyst Coverage
Buzzberg tracks DAWN (Day One Biopharmaceuticals) across 2 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked.